Research advances in interferon-stimulated genes in treatment of hepatitis B virus infection / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 180-186, 2022.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-913138
Responsible library:
WPRO
ABSTRACT
Hepatitis B virus (HBV) infection is closely associated with the adverse events such as liver cirrhosis, liver cancer, and liver failure and remains a serious threat to human health. Pegylated interferon is an indispensable drug for the treatment of chronic hepatitis B (CHB), and interferon-stimulated genes are associated with a variety of viruses, but few studies have mentioned their association with hepatitis B and their predictive effect after the treatment of hepatitis B with interferon. This article introduces the predictive factors for interferon treatment of CHB and summarizes the association of interferon-stimulated genes with hepatitis B and their predictive effect, so as to provide a reference for clinical work and basic research.
Full text:
Available
Database:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Journal of Clinical Hepatology
Year:
2022
Document type:
Article